Diseases & Disorders
(G30)
990 on File
NORTHEAST REGIONAL CANCER INSTITUTE
Financial strength (30%)
87/100
Reliability (20%)
45/100
Effectiveness (25%)
85/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$1.3M
Total Revenue
$1.5M
Total Expenses
$4.5M
Net Assets
22
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
79.6%
Fundraising Efficiency
10.9%
Operating Reserve
35.30x
Liability-to-Asset
4.6%
Revenue Diversification
56.4%
Executive Compensation
$394K
Compared with Peers
FY 2024
Compared with 640 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
79.6% | 82.3% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
19.8% | 11.5% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.5% | 2.8% |
P10P90
|
Above median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
10.9% | 111.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
35.3 mo | 11.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
4.6% | 12.7% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
56.4% | 91.5% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-11.1% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
1.2% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-16.8% | 1.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $1.3M | $1.5M | $4.5M | 79.6% | 22 |
| 2023 | $1.5M | $1.5M | $4.3M | 80.3% | 24 |
| 2022 | $1.2M | $1.5M | $4.0M | 80.5% | 22 |
| 2021 | $1.3M | $1.5M | N/A | — | 23 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.